World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 84 14799 13930 7481 6926 236 96976

Scott L. Pomeroy publications per year

The chart shows the history of publications by Scott L. Pomeroy between 1978 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Scott L. Pomeroy published across 48 years, from 1978 to 2025, averaging 5.4 papers a year. Output peaked at 20 publications in 2012. 5 of the 258 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1978 to 2025. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2012. 1978: 1 publication 1979: 1 publication 1980: 1 publication 1981: 1 publication 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 1 publication 1989: 0 publications 1990: 3 publications 1991: 1 publication 1992: 2 publications 1993: 0 publications 1994: 5 publications 1995: 3 publications 1996: 3 publications 1997: 5 publications 1998: 0 publications 1999: 7 publications 2000: 6 publications 2001: 4 publications 2002: 6 publications 2003: 15 publications 2004: 6 publications 2005: 8 publications 2006: 6 publications 2007: 4 publications 2008: 9 publications 2009: 4 publications 2010: 11 publications 2011: 17 publications 2012: 20 publications 2013: 11 publications 2014: 16 publications 2015: 3 publications 2016: 9 publications 2017: 14 publications 2018: 6 publications 2019: 7 publications 2020: 7 publications 2021: 8 publications 2022: 2 publications 2023: 20 publications 2024: 3 publications 2025: 2 publications
1978 2025

258 publications in total across all disciplines

View publications per year as a table
Scott L. Pomeroy: publications per year, 1978 to 2025
Year Publications
1978 1
1979 1
1980 1
1981 1
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 1
1989 0
1990 3
1991 1
1992 2
1993 0
1994 5
1995 3
1996 3
1997 5
1998 0
1999 7
2000 6
2001 4
2002 6
2003 15
2004 6
2005 8
2006 6
2007 4
2008 9
2009 4
2010 11
2011 17
2012 20
2013 11
2014 16
2015 3
2016 9
2017 14
2018 6
2019 7
2020 7
2021 8
2022 2
2023 20
2024 3
2025 2
Total 258
Download as CSV

Scott L. Pomeroy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Scott L. Pomeroy sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 221–240 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 236 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487 236
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Scott L. Pomeroy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Scott L. Pomeroy sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 84–85 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003 84
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2017 - Member of the National Academy of Medicine (NAM)

Overview

Scott L. Pomeroy is affiliated with Boston Children's Hospital in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular focus on Molecular Biology, Genetics, and Cancer Research. Additional subfields include Pulmonary and Respiratory Medicine, as well as Public Health, Environmental and Occupational Health.

The scientist's work covers a range of topics related to cancer and neurological conditions. Key areas of study include:

  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Genomics and Chromatin Dynamics
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Cancer-related molecular mechanisms research
  • RNA Research and Splicing

Recent publications by Scott L. Pomeroy demonstrate active involvement in cancer and developmental biology research. Selected papers include:

  • "Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma," 2021, Journal of Clinical Oncology
  • "Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma," 2023, Nature Genetics
  • "WNT signalling control by KDM5C during development affects cognition," 2024, Nature
  • "Developmental basis of SHH medulloblastoma heterogeneity," 2024, Nature Communications
  • "Loss of Consciousness in the Young Child," 2021, Pediatric Cardiology

Scott L. Pomeroy frequently collaborates with several coauthors, reflecting interdisciplinary work in their research areas. Notable frequent coauthors include:

  • Jill P. Mesirov
  • Ernest Fraenkel
  • Robert J. Wechsler-Reya
  • Lukas Chávez
  • Owen Chapman

The scientist's research output is often published in venues such as Annals of Neurology, bioRxiv (Cold Spring Harbor Laboratory), Journal of Clinical Oncology, Nature Genetics, and Nature. Annals of Neurology represents the most common publication venue.

In recognition of their contributions, Scott L. Pomeroy became a member of the National Academy of Medicine (NAM) in 2017.

Best Publications

  • Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

    Aravind Subramanian;Pablo Tamayo;Vamsi K. Mootha;Sayan Mukherjee

  • The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

  • Prediction of central nervous system embryonal tumour outcome based on gene expression

    Scott L. Pomeroy;Pablo Tamayo;Michelle Gaasenbeek;Lisa M. Sturla

  • Molecular Subgroups of Medulloblastoma: The Current Consensus

    Michael D. Taylor;Paul A. Northcott;Andrey Korshunov;Marc Remke;Marc Remke

  • Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

    Leonora Balaj;Ryan Lessard;Lixin Dai;Yoon Jae Cho

  • Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

    Catherine L. Nutt;D. R. Mani;Rebecca A. Betensky;Pablo Tamayo

  • Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

    Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones

  • Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia

  • The whole-genome landscape of medulloblastoma subtypes

    Paul A. Northcott;Paul A. Northcott;Ivo Buchhalter;Ivo Buchhalter;A. Sorana Morrissy;Volker Hovestadt

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

    Trevor J Pugh;Trevor J Pugh;Shyamal Dilhan Weeraratne;Shyamal Dilhan Weeraratne;Tenley C. Archer;Tenley C. Archer;Daniel A. Pomeranz Krummel

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

    Yoon Jae Cho;Aviad Tsherniak;Pablo Tamayo;Sandro Santagata

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance

    Max A. Tischfield;Hagit N. Baris;Chen Wu;Guenther Rudolph

  • Medulloblastomics: the end of the beginning

    Paul A. Northcott;David T.W. Jones;Marcel Kool;Giles W. Robinson

  • Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation

    Boris G. Wilson;Xi Wang;Xiaohua Shen;Elizabeth S. McKenna

  • Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

    S. C. Mack;H. Witt;R. M. Piro;L. Gu

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • ErratumEpigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation

    Boris G. Wilson;Xi Wang;Xiaohua Shen;Elizabeth S. McKenna

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Michael D. Taylor
Michael D. Taylor University of Toronto
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Paul A. Northcott
Paul A. Northcott St. Jude Children's Research Hospital
Marc Remke
Marc Remke German Cancer Research Center
Marcel Kool
Marcel Kool German Cancer Research Center
Pablo Tamayo
Pablo Tamayo University of California, San Diego
David T. W. Jones
David T. W. Jones German Cancer Research Center
Mark W. Kieran
Mark W. Kieran Harvard University
Charles G. Eberhart
Charles G. Eberhart Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees opens up a variety of career pathways for those interested in Medicine in the USA. Many students are now seeking flexible and affordable education options beyond traditional medical school. For those interested in healthcare management, some of the most cheap mha programs can provide essential administrative skills without significant financial burden.

Advanced nursing roles are also in high demand. Prospective nurse practitioners and clinical leaders should look for the most affordable online dnp programs to pursue their goals without compromising on quality.

Pharmacists play a crucial part in healthcare delivery. For those considering pharmacy, enrolling in a pharmacy degree online can be a flexible way to enter the field while managing other responsibilities.

High school students interested in early healthcare pathways can start their journey with the best online schools for high school students specializing in health information management.

These online programs offer affordability, accessibility, and opportunities for advancement across multiple healthcare specialties.

Best Scientists Citing Scott L. Pomeroy

Trending Scientists

Recently Published Articles